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410a Monday, February 17, 2014hematopoietic cells, is significantly overexpressed in GBM. It is believed that
LYN promotes migration of cancer cells, thus advancing the malignancy. This
research addresses computational design of small druglike molecules that could
potentially inhibit LYN and thus stave off the cancer advancement. LYN has a
very similar binding site to the polo-box domain (PBD) in Polo-like kinase 1
(Plk1). Plk1 is a main regulator of mitosis. Considering the key cellular roles
of both LYN and Plk1, it is important to design inhibitors that will specifically
bind to LYN. In this work, physical and chemical properties of the binding sites
of LYN and Plk1 were investigated and compared. Pertinent atomic distances
within the LYN binding site were found to be smaller than those within the
PBD of Plk1. The two sites also differed in their flexibilities. By utilizing the
differences, novel molecules were designed that could potentially bind LYN
with higher affinities than they could Plk1. Previously designed molecules
that bonded both LYN and Plk1 were used as initial templates to design
more specific inhibitors. Potential toxicities and drug-likeness of the molecules
were evaluated. Molecules with no implied toxicities and optimal druglike
properties were used for docking studies. Molecules that made the most stable
docking configurations with LYN and with no other kinases were identified as
LYN-specific. Binding energies of the stable complexes that these molecules
formed with LYN were calculated. Possible utilization of the designed mole-
cules against tumors with overexpressed LYN is discussed.
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The complexities of the brain are hidden in the always active neuron commu-
nication. The propagation of the neuron signals is carried out by neurotransmit-
ters. It is obvious why the signals activation is important but the signal
quenching is just at important in proper brain function. The length of the stimuli
and in turn the intensity are controlled by the neurotransmitter transporters.
The clearing of the neurotransmitters from the synapse is the responsibility of
transporters. Each neurotransmitter has its specific transporter. The main ones
being Serotonin, Dopamine, and Norepinephrine Transporters (SERT, DAT,
and NET). As a class of secondary transporters the sodium:neurotransmitter
symporters utilize a sodium ion gradient to co-transport a neurotransmitter
molecule against its gradient. The coupling of the ions favourable free energy
to the unfavourable recycling of the neurotransmitters is the crucial step in de-
ciphering the mechanism of transport.
The interaction between the substrate and protein are key to proper transport.
However these transporters are very common targets not only for the neuro-
transmitters but many medicinal and psychedelic drugs. Our focus is on
exploring similarities between the substrates and what properties make them
likely to target transporters. Also we wish to explore the binding differences
experimentally observed in different enantiomers of methamphetamines (crys-
tal meth) and 3,4-methylenedioxymethamphetamine (ecstasy). We have used
homology modelling to model hDAT and hSERT in three different conforma-
tions (open-to-out, open-to-in, and occluded). These six structures will be used
to explore the differences between the S and R enantiomers. Like many biolog-
ical systems preference is given to one conformation over the other, with S
enantiomer being the highly preferred one.
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Significance: Aberrant protein-protein interactions are a hallmark of disease
and many cancers. Disrupting these interactions is a current therapeutic strat-
egy. However, developing inhibitors for protein-protein interfaces (PPI) re-
mains challenging due to large surface area over which these interactions
occur. Computational methods can greatly aid in identifying druggable sites
on the PPI enabling rational inhibitor design for PPI.
Approach: We have developed a computational method termed FindBindSite
(FBS), to identify druggable sites in the PPI starting from free monomer struc-
tures. Our method virtually screens a small database of compounds or dipep-
tides over the entire protein surface and identifies regions with high docked
ligand atom density. Densely populated regions are then clustered and scored
based on cluster size. The clustering allows us to identify binding surfaces in
the interface regions.
Results: FBS was validated 41 protein-protein structures crystallized in com-
plex form. Structures were selected giving preference to free, protein-
inhibitor, and then protein-protein complex when structures were not available.
We predicted binding sites in interface regions of 71% with a high confidenceand 90% with a low confidence using our test set. We tested the performance of
FBS on homology models of free monomers achieving a hit rate of 68% when
using templates with sequence identity between 20-97%. Applying a 60%
sequence identity cutoff we achieved a hit rate of 86%. Using a library of di-
peptides we were able to achieve 85% hit rate. We demonstrate that FBS is a
useful computational method to predict binding sites in protein-protein inter-
faces because it uses the probe molecule diversity to span beyond well formed
pockets and identify regions where one could likely disrupt any PPIs are likely
to occur.
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Integrin receptors play a critical role in mediating early events in cells
adhering to ECM and synthetic peptides on surfaces. To better understand
the sensitivity of peptide sequences to a specific integrin types and between
integrins we performed a computational analysis. Specifically we began by
sequence based homologies between the three integrin receptors (3VI4,
3ZE2, and 1L5G) for which crystal structures are available. Using the homol-
ogy study as a starting point we developed some hypothesis on potential sim-
ilarities and differences to be expected with respect to their function. As the
next step we performed computational docking simulations of the library of
peptides (19) against each of these peptides using Autodock. For these simu-
lations we primarily used the co-crystal structure (integrin/RGD PDB name
3ZE2) implicated binding pocket as the focus of our studies. Based on these
docking simulations we have generated a number of different binding ensem-
bles for each peptide for a given integrin receptor. From the top docking con-
figurations (based on visual inspection, grouping, and Autodock Binding
scores), we then performed steered molecular dynamics simulations to
generate a potential of mean force for the peptides against the receptors.
These values then serve as starting point into a multi-scale simulation study
being used to estimate the adhesion of the entire cell to an ECM/functional-
ized surface.
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In protein-protein interaction predictions, there are various approaches to
obtain near-native 3D structure of protein complexes. One of the most available
methods is rigid-body docking process, generating many protein complexes
(decoys) as candidates of the native complex.
However, we sometime faced with one of the critical problems to solve, which
is a situation of no near-native decoys including a decoy dataset. Even if the
bound-state case, in 9 out of 44 protein pairs, we could not obtain near-
native decoys. To overcome this situation, we applied interaction fingerprint
(IFP) to this problem. IFP method in docking process is originally developed
for cluster analysis by comparing among decoys in our previous work [Uchi-
koga & Hirokawa, (2010) BMC Bioinfor. 11:264]. This method can applied
to proteins with large conformation changes, for example, calmodulin. IFP
composed of frequencies of interaction between amino acid residues. There-
fore, much more different structures can compare each other.
The critical situation of no near-native decoys results from a fact that docking
search space is not large enough to obtain near-native decoys. Therefore, we
proposed re-docking scheme for exploring docking search spaces by restrict-
ing protein surfaces after assembling interaction surfaces of decoys using
IFPs. We applied re-docking scheme to several docking cases and will discuss
the results.
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Several myelin-associated proteins, the neurite outgrowth inhibitor
(Nogo), myelin-associated glycoprotein (MAG), and oligodendrocyte-myelin
Monday, February 17, 2014 411aglycoprotein (OMgp), contribute to inhibit central nerve system (CNS) regen-
eration after injuries; mainly by blocking axonal regrowth. The neurite
outgrowth inhibitor (Nogo-A) is a multi-domain transmembrane (TM) protein.
The loop domain, connecting the two hydrophobic C-terminus TM helices, is
referred to as Nogo-66. The inhibitory effect of Nogo is established when
Nogo-66 binds to its receptor (NgR) on the axon. Based on mutagenesis
studies performed in our lab, residues Ser 38, Asn 39, Ser 40, Leu 42, Arg
53 and Arg 54 affected the binding of Nogo-66 to NgR. Arg 53 and Arg 54
are among the most affected residues. On the other hand, combinatorial studies
on NgR, Asp 111, Asp 114, Asp 163 are the most residues contributing to the
interaction of NgR with Nogo-66 (1). To confirm this observation, High Am-
biguity Driven Docking (HADDOCK) expert interface server was used (2). As
starting structures for docking studies, we used the crystal structure of NgR
(PDB id 1OZN) and the NMR solution structure of Nogo-66 (PDB id
2KO2). The complex structures resulted from HADDOCK studies were in
agreement with our mutagenesis studies and provide insight into the mecha-
nism of inhibition.
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Protein-protein and protein-ligand recognition plays an essential role in many
biomolecular processes. Understanding the mechanisms of protein-ligand bind-
ing is also crucial for designing new and optimizing existing therapeutic agents,
and in different biotechnological applications. It is well known that solvation
effects, including hydrophobicity and solvent mediated hydrogen bonding,
are major factors implicated in biomolecular processes. Such processes often
involve slow conformational changes and exchange of solvent and ligand mol-
ecules between bulk solution and biomolecular cavities.
We develop new approaches for accurate account of molecular solvation ef-
fects in protein-ligand recognition and binding, which further extend the ligand
mapping protocols based on the molecular theory of solvation, a.k.a. the three-
dimensional reference interaction site model with the Kovalenko-Hirata
closure (3D-RISM-KH). Based on statistical mechanics, this theory provides
a natural link between different levels of coarse-graining details in a multiscale
description of solvation structure and thermodynamics, from highly localized
structural solvent and bound ligand molecules to effective desolvation poten-
tials and self-assembling nanoarchitectures in solvents of different composition
in a range of thermodynamic conditions.
Implemented in the new 3D-RISM-Dock protocol, the theory provides a quan-
titative estimate of binding affinities, based on a detailed physical description of
hydrogen bonding, hydrophobicity, and solvation entropic effects, with full ac-
count for molecular specificities, thermodynamic conditions, and concentration
effects. The theory accurately predicts the solvation structure of biomolecules.
This allows us to incorporate the 3D-RISM-KH description of structural solva-
tion in a new docking protocol. The latter has been successfully applied to pre-
dict the binding modes of the periplasmic binding proteins in situations when
structural solvation and desolvation effects are of importance. We also show
that the 3D-RISM-KH theory provides valuable information on the role of
the solvation entropic effects in the ligand binding and large scale conformation
dynamics of proteins.
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A simple and powerful method for enhancing conformational transitions of
proteins, referred as "Fluctuation Flooding Method (FFM)", is proposed. In
FFM, biologically relevant anisotropic fluctuations of proteins are firstly
characterized by the principal component analysis (PCA) from trajectories
of molecular dynamics (MD) simulations. Then largely fluctuated snapshots
along the anisotropic directions are assumed as candidates that tend to induceconformational transitions with high probabilities and selected as initial struc-
tures for Multiple Independent Molecular Dynamics (MIMD) simulations. In
MIMD, a series of short time MD simulations are performed with re-
generating initial velocities for selected candidates to enhance conformational
transitions. Due to the re-organizations of the initial velocities, some of the can-
didates might make a conformational transition to another meta-stable states.
The multiple trajectories from MIMD are characterized by the PCA to extract
largely fluctuated snapshots as candidates for the next MIMD step. These pro-
cedures are repeated until distributions of the conformational sampling are well
converged. In addition to FFM, Multiple Independent Umbrella Sampling
(MIUS) using reference structures selected from MIMD can provide Free En-
ergy Landscape (FEL). FEL calculations by the combination with MIUS enable
us to quantitatively determine conformational transition pathways and estimate
structural stabilities of newly found meta-stable states.
To assess the reliability of the proposed method, we applied FFM to a toy
model and confirmed that probability densities calculated from FFM showed
a good agreement with the analytical solution. As an application to a real pro-
tein system, we applied FFM to T4-Lysozome in explicit water. Although 1-ms
canonical MD failed to sample the closed state, FFM with 10-ns MIMD suc-
ceeded in finding conformational transitions from the open to closed states,
where the minimum root-mean square deviation between the predicted closed
and experimental X-ray structures was 0.76 A˚.
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Mutational analysis is the bread and butter of experimental protein biophysics;
however, in simulation studies, mutational analysis remains a major challenge
because the computational costs scale proportional to the number of mutants.
We suggest a way out of this connundum, by using large-scale simulation of
a wild-type protein as an informative prior on the simulations of mutants.
With an ansatz that mutation perturbs the rates of inter-conversion between
an unknown subset of the conformational states of the protein, we introduce
a Bayesian adaptive simulation framework in which these perturbations are
automatically perused and discovered in a maximum expected information
gain criterion. Preliminary data suggests that this approach can lead to speedups
on the order of ten times in simulations of mutants, by focusing molecular dy-
namics sampling in regions of phase-space that are perturbed with respect to the
wild-type.
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Adverse drug reactions are a leading cause of morbidity and mortality with esti-
mated annual in-patient costs of over $100 billion in the US alone. A growing
number of the most sever adverse reactions, termed idiosyncratic hypersensitiv-
ities, are observed to be immune system mediated with genetic associations to
specific patient human leukocyte antigen (HLA) alleles. However, the underly-
ing mechanisms of such genetic associations are still unclear. Improved knowl-
edge of these mechanisms is highly desirable for prognosis and prevention as
well as the optimal utilization of drug therapies. Recently, we combined in sil-
ico and in vitro approach to demonstrate that the antiviral drug abacavir can
bind inside the antigen binding cleft of HLA B*57:01 and alter its specificity
for self-peptides presented to T cells. This finding, which has been indepen-
dently reproduced, supports a new drug induced "altered peptide repertoire
model" for HLA-drug associated hypersensitivities and explains the specificity
of abacavir for HLA B*57:01 over other alleles. Here we describe the com-
bined application of structural modeling, molecular docking and molecular dy-
namics simulations to further examine the generality of this model to additional
drugs with known HLA-drug associated hypersensitivities. The predictive po-
wer of our in silico approach was evaluated with a benchmark containing mixed
drug hypersensitivity associated and unassociated HLA alleles. The critical en-
ergetic features of HLA-drug binding were further investigated via molecular
dynamics simulations. For abacavir, the antiepileptic drug carbamazepine,
and the antihyperuricemic drug allopurinol these simulations identified the
variant specific residue-wise determinants of HLA-drug interactions. Our
studies represent a first step toward the development of preclinical screening
processes that aims to highlight drugs with a high risk of causing drug hyper-
sensitivity.
